Lacosamide Accord

Lacosamide, the active ingredient in Lacosamide Accord, is a sodium channel blocker presented as an injection for intravenous use. It treats partial‑onset seizures in patients with epilepsy.

GNH USA supplies Lacosamide Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an antiepileptic drug that acts on neuronal sodium channels to control seizure activity. - Partial‑onset seizures: reduces seizure frequency in patients with focal epilepsy. - Adjunct therapy in refractory epilepsy: added when seizures are not adequately controlled by other antiepileptics. - Secondary generalized seizures: helps prevent progression of focal seizures to generalized convulsions.

Lacosamide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Nausea: feeling of stomach upset or urge to vomit. - Headache: mild to moderate pain in the head region. - Fatigue: unusual tiredness or lack of energy. - Blurred vision: temporary visual disturbances. - Somnolence: increased sleepiness during the day.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm, including atrioventricular block. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hypersensitivity: rash, swelling, or anaphylactic response. - Respiratory depression: slowed breathing, especially with concomitant depressants. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Severe hypotension: marked drop in blood pressure.

When using Lacosamide Accord, clinicians should consider several safety aspects. - Renal impairment: monitor renal function and adjust therapy as needed. - Cardiac conduction disorders: obtain baseline ECG and watch for arrhythmias. - Pregnancy: prescribe only if potential benefit justifies potential risk to the fetus. - Concomitant CNS depressants: observe for enhanced sedation or respiratory effects. - Hypersensitivity: discontinue immediately if allergic reaction occurs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lacosamide can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase lacosamide plasma concentrations. - Class I antiarrhythmics: additive effects on cardiac conduction. - Other sodium channel blockers: heightened risk of central nervous system depression.

Moderate Interactions (Monitor Closely): - Carbamazepine: may reduce lacosamide levels, decreasing effectiveness. - Phenytoin: can alter lacosamide plasma concentrations. - Alcohol: may potentiate CNS side effects such as dizziness and somnolence.